HK Stock MarketDetailed Quotes

01515 CR MEDICAL

Watchlist
  • 4.130
  • 0.0000.00%
Market Closed Nov 12 16:08 CST
5.36BMarket Cap16.65P/E (TTM)

CR MEDICAL Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
----
16.55%492.92M
----
56.37%422.94M
----
-35.32%270.48M
----
-22.74%418.19M
----
-8.09%541.3M
Profit adjustment
Interest (income) - adjustment
----
8.59%-85.33M
----
-20.54%-93.35M
----
3.11%-77.45M
----
-23.00%-79.93M
----
2.17%-64.98M
Dividend (income)- adjustment
----
-19.14%-3.87M
----
-16.24%-3.25M
----
-6.76%-2.8M
----
-398.67%-2.62M
----
77.36%-525K
Attributable subsidiary (profit) loss
----
-3.08%-90.78M
----
-5.40%-88.07M
----
-138.94%-83.55M
----
-652.65%-34.97M
----
-116.39%-4.65M
Impairment and provisions:
----
252.24%481.37M
----
-61.54%136.66M
----
1,410.26%355.29M
----
1,391.76%23.53M
----
2,326.15%1.58M
-Impairment of property, plant and equipment (reversal)
----
41,231.18%210.79M
----
--510K
----
----
----
----
----
----
-Impairmen of inventory (reversal)
----
1,036.84%216K
----
--19K
----
----
----
----
----
----
-Impairment of goodwill
----
30.18%141.02M
----
--108.32M
----
----
----
----
----
----
-Other impairments and provisions
----
365.18%129.35M
----
-92.17%27.81M
----
1,410.26%355.29M
----
1,391.76%23.53M
----
2,326.15%1.58M
Revaluation surplus:
----
393.48%16.52M
----
-120.53%-5.63M
----
9.06%27.42M
----
86.35%25.14M
----
370.25%13.49M
-Other fair value changes
----
393.48%16.52M
----
-120.53%-5.63M
----
9.06%27.42M
----
86.35%25.14M
----
370.25%13.49M
Asset sale loss (gain):
----
144.43%2.39M
----
---5.37M
----
----
----
----
----
200.00%795K
-Loss (gain) from sale of subsidiary company
----
----
----
---5.68M
----
----
----
----
----
----
-Loss (gain) on sale of property, machinery and equipment
----
671.84%2.39M
----
--309K
----
----
----
----
----
-49.04%795K
Depreciation and amortization:
----
28.67%595.58M
----
153.10%462.87M
----
61.29%182.88M
----
78.15%113.38M
----
-12.80%63.64M
-Amortization of intangible assets
----
-2.60%6.52M
----
0.01%6.69M
----
-15.25%6.69M
----
-57.88%7.9M
----
-10.82%18.75M
-Other depreciation and amortization
----
35.07%-15.28M
----
---23.53M
----
----
----
----
----
----
Financial expense
----
85.30%131.84M
----
298.95%71.15M
----
2.55%17.83M
----
2.65%17.39M
----
120.00%16.94M
Exchange Loss (gain)
----
-51.10%77.69M
----
692.87%158.88M
----
39.53%-26.8M
----
-464.48%-44.31M
----
-28.33%12.16M
Special items
----
----
----
-81.02%1.92M
----
454.24%10.11M
----
-121.62%-2.85M
----
348.42%13.2M
Operating profit before the change of operating capital
----
52.85%1.62B
----
57.22%1.06B
----
55.54%673.41M
----
-26.99%432.94M
----
-1.94%592.95M
Change of operating capital
Inventory (increase) decrease
----
476.00%65.18M
----
-8,316.11%-17.34M
----
100.91%211K
----
-247.77%-23.29M
----
142.28%15.76M
Accounts receivable (increase)decrease
----
-226.34%-120.28M
----
-30.77%95.2M
----
48.30%137.52M
----
174.59%92.73M
----
-5.34%-124.32M
Accounts payable increase (decrease)
----
-26.41%-219.28M
----
-60.52%-173.46M
----
-144.84%-108.06M
----
517.85%240.97M
----
2,368.48%39M
prepayments (increase)decrease
----
----
----
----
----
17,023.27%132.34M
----
-173.22%-782K
----
300.75%1.07M
Special items for working capital changes
----
-599.06%-38.94M
----
160.75%7.8M
----
-25.69%-12.84M
----
-284.71%-10.22M
----
-106.52%-2.66M
Cash  from business operations
----
34.40%1.31B
----
18.04%970.97M
----
12.32%822.58M
----
40.35%732.35M
----
6.24%521.81M
Other taxs
----
-13.60%-163.4M
----
-5.77%-143.84M
----
-38.38%-135.99M
----
40.03%-98.27M
----
-0.73%-163.88M
Interest received - operating
----
46.78%53.51M
----
52.90%36.46M
----
148.04%23.84M
----
18.33%9.61M
----
42.78%8.12M
Special items of business
-6.05%507.76M
----
459.47%540.44M
----
-24.18%96.6M
----
-43.40%127.41M
----
3,067.93%225.11M
----
Net cash from operations
-6.05%507.76M
38.39%1.2B
459.47%540.44M
21.56%863.59M
-24.18%96.6M
10.37%710.43M
-43.40%127.41M
75.85%643.69M
3,067.93%225.11M
9.55%366.05M
Cash flow from investment activities
Dividend received - investment
-7.28%3.59M
1,990.00%92.75M
19.14%3.87M
58.78%4.44M
16.24%3.25M
6.76%2.8M
6.76%2.8M
398.67%2.62M
398.67%2.62M
-77.36%525K
Loan receivable (increase) decrease
45.94%3.49M
-40.84%7.39M
-35.23%2.39M
11.63%12.49M
54.46%3.69M
-41.87%11.19M
-47.57%2.39M
113.32%19.25M
214.00%4.55M
-42.31%9.02M
Decrease in deposits (increase)
-386.13%-9.49M
-838.55%-25.41M
369.59%3.32M
-73.25%3.44M
-107.06%-1.23M
173.85%12.86M
335.11%17.42M
---17.42M
120.39%4M
----
Sale of fixed assets
-33.99%5.23M
797.10%54.98M
104.70%7.93M
192.41%6.13M
86.60%3.87M
-71.67%2.1M
177.78%2.08M
99.43%7.4M
105.79%747K
29.86%3.71M
Purchase of fixed assets
-28.24%-248.39M
-4.38%-486.68M
-78.22%-193.69M
-134.98%-466.28M
-46.22%-108.68M
5.30%-198.43M
-328.43%-74.33M
-476.23%-209.55M
-85.00%-17.35M
36.87%-36.37M
Purchase of intangible assets
----
----
----
----
----
-260.30%-28.82M
----
---8M
----
----
Sale of subsidiaries
----
-75,360,740.00%-3.77B
----
--5K
--50K
----
----
----
----
----
Acquisition of subsidiaries
----
----
----
126.70%173.92M
120.25%173.92M
-656.53%-651.28M
-832.63%-858.76M
39,108.67%117.03M
--117.22M
88.70%-300K
Recovery of cash from investments
-97.90%55.6M
-25.58%3.57B
28.19%2.65B
12.05%4.79B
34.19%2.07B
-38.23%4.28B
-59.44%1.54B
18.48%6.92B
39.22%3.8B
16.46%5.84B
Cash on investment
97.82%-55M
38.76%-2.68B
-18.19%-2.53B
18.35%-4.38B
25.15%-2.14B
20.78%-5.37B
39.74%-2.86B
-19.13%-6.77B
-74.20%-4.74B
-17.25%-5.69B
Other items in the investment business
-103.64%-16.31M
197.15%620.19M
--448.04M
-18,847.90%-638.37M
----
--3.41M
150.49%4.09M
----
-134.25%-8.09M
7,973.00%23.62M
Net cash from investment operations
-165.53%-261.29M
-430.77%-2.62B
5,417.64%398.71M
74.48%-494.02M
100.33%7.23M
-3,307.23%-1.94B
-166.31%-2.22B
-61.61%60.37M
-10,833.53%-832.6M
-55.76%157.24M
Net cash before financing
-73.75%246.48M
-486.12%-1.43B
804.55%939.14M
130.15%369.57M
104.97%103.82M
-274.08%-1.23B
-244.03%-2.09B
34.54%704.05M
-4,187.24%-607.49M
-24.11%523.29M
Cash flow from financing activities
New borrowing
-41.22%1.14B
-35.52%5.55B
-55.85%1.94B
41.85%8.61B
47.96%4.39B
1,233.95%6.07B
2,139.09%2.97B
386.18%455.24M
1,421.75%132.59M
-69.16%93.64M
Refund
32.41%-1.28B
33.03%-5.77B
56.98%-1.9B
-69.39%-8.62B
-122.59%-4.41B
-1,513.32%-5.09B
---1.98B
-1,738.65%-315.44M
----
-40,747.62%-17.16M
Interest paid - financing
43.32%-30.88M
-106.16%-116.27M
-302.93%-54.49M
-185.20%-56.4M
-65.06%-13.52M
-39.06%-19.77M
11.78%-8.19M
15.52%-14.22M
-86.82%-9.29M
-147.54%-16.83M
Dividends paid - financing
----
57.33%-55.53M
-2,085.82%-11.87M
-30.20%-130.14M
99.40%-543K
20.49%-99.96M
21.34%-91.08M
11.72%-125.73M
-958.89%-115.78M
-9.83%-142.42M
Absorb investment income
----
----
----
----
----
-65.46%544K
----
1.29%1.58M
-24.03%980K
-27.30%1.56M
Other items of the financing business
----
----
----
---474K
----
----
-345.42%-724K
-100.30%-127K
-99.27%295K
120.09%42.99M
Net cash from financing operations
-426.70%-192.27M
-95.40%-437.08M
17.57%-36.5M
-126.44%-223.69M
-105.03%-44.29M
11,559.71%845.96M
11,387.69%879.84M
81.98%-7.38M
-55.44%7.66M
8.39%-40.97M
Effect of rate
-73.78%183K
-94.84%141K
-60.00%698K
16.84%2.73M
139.91%1.75M
253.85%2.34M
-461.02%-4.37M
-441.28%-1.52M
256.87%1.21M
-112.37%-281K
Net Cash
-93.99%54.21M
-1,377.84%-1.86B
1,416.10%902.64M
138.42%145.88M
104.92%59.54M
-154.50%-379.66M
-101.74%-1.21B
44.44%696.67M
-1,971.48%-599.83M
-25.20%482.33M
Begining period cash
-60.13%1.24B
5.04%3.1B
5.04%3.1B
9.26%2.95B
9.26%2.95B
34.65%2.7B
34.65%2.7B
31.63%2.01B
31.63%2.01B
73.78%1.52B
Cash at the end
-67.76%1.29B
-60.13%1.24B
32.88%4B
33.39%3.1B
102.61%3.01B
-13.97%2.32B
5.63%1.49B
34.65%2.7B
-9.51%1.41B
31.63%2.01B
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
KPMG
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024 (FY)Dec 31, 2023 (Q6)Jun 30, 2023 (FY)Dec 31, 2022 (Q6)Jun 30, 2022 (FY)Dec 31, 2021 (Q6)Jun 30, 2021 (FY)Dec 31, 2020 (Q6)Jun 30, 2020 (FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax ---- 16.55%492.92M ---- 56.37%422.94M ---- -35.32%270.48M ---- -22.74%418.19M ---- -8.09%541.3M
Profit adjustment
Interest (income) - adjustment ---- 8.59%-85.33M ---- -20.54%-93.35M ---- 3.11%-77.45M ---- -23.00%-79.93M ---- 2.17%-64.98M
Dividend (income)- adjustment ---- -19.14%-3.87M ---- -16.24%-3.25M ---- -6.76%-2.8M ---- -398.67%-2.62M ---- 77.36%-525K
Attributable subsidiary (profit) loss ---- -3.08%-90.78M ---- -5.40%-88.07M ---- -138.94%-83.55M ---- -652.65%-34.97M ---- -116.39%-4.65M
Impairment and provisions: ---- 252.24%481.37M ---- -61.54%136.66M ---- 1,410.26%355.29M ---- 1,391.76%23.53M ---- 2,326.15%1.58M
-Impairment of property, plant and equipment (reversal) ---- 41,231.18%210.79M ---- --510K ---- ---- ---- ---- ---- ----
-Impairmen of inventory (reversal) ---- 1,036.84%216K ---- --19K ---- ---- ---- ---- ---- ----
-Impairment of goodwill ---- 30.18%141.02M ---- --108.32M ---- ---- ---- ---- ---- ----
-Other impairments and provisions ---- 365.18%129.35M ---- -92.17%27.81M ---- 1,410.26%355.29M ---- 1,391.76%23.53M ---- 2,326.15%1.58M
Revaluation surplus: ---- 393.48%16.52M ---- -120.53%-5.63M ---- 9.06%27.42M ---- 86.35%25.14M ---- 370.25%13.49M
-Other fair value changes ---- 393.48%16.52M ---- -120.53%-5.63M ---- 9.06%27.42M ---- 86.35%25.14M ---- 370.25%13.49M
Asset sale loss (gain): ---- 144.43%2.39M ---- ---5.37M ---- ---- ---- ---- ---- 200.00%795K
-Loss (gain) from sale of subsidiary company ---- ---- ---- ---5.68M ---- ---- ---- ---- ---- ----
-Loss (gain) on sale of property, machinery and equipment ---- 671.84%2.39M ---- --309K ---- ---- ---- ---- ---- -49.04%795K
Depreciation and amortization: ---- 28.67%595.58M ---- 153.10%462.87M ---- 61.29%182.88M ---- 78.15%113.38M ---- -12.80%63.64M
-Amortization of intangible assets ---- -2.60%6.52M ---- 0.01%6.69M ---- -15.25%6.69M ---- -57.88%7.9M ---- -10.82%18.75M
-Other depreciation and amortization ---- 35.07%-15.28M ---- ---23.53M ---- ---- ---- ---- ---- ----
Financial expense ---- 85.30%131.84M ---- 298.95%71.15M ---- 2.55%17.83M ---- 2.65%17.39M ---- 120.00%16.94M
Exchange Loss (gain) ---- -51.10%77.69M ---- 692.87%158.88M ---- 39.53%-26.8M ---- -464.48%-44.31M ---- -28.33%12.16M
Special items ---- ---- ---- -81.02%1.92M ---- 454.24%10.11M ---- -121.62%-2.85M ---- 348.42%13.2M
Operating profit before the change of operating capital ---- 52.85%1.62B ---- 57.22%1.06B ---- 55.54%673.41M ---- -26.99%432.94M ---- -1.94%592.95M
Change of operating capital
Inventory (increase) decrease ---- 476.00%65.18M ---- -8,316.11%-17.34M ---- 100.91%211K ---- -247.77%-23.29M ---- 142.28%15.76M
Accounts receivable (increase)decrease ---- -226.34%-120.28M ---- -30.77%95.2M ---- 48.30%137.52M ---- 174.59%92.73M ---- -5.34%-124.32M
Accounts payable increase (decrease) ---- -26.41%-219.28M ---- -60.52%-173.46M ---- -144.84%-108.06M ---- 517.85%240.97M ---- 2,368.48%39M
prepayments (increase)decrease ---- ---- ---- ---- ---- 17,023.27%132.34M ---- -173.22%-782K ---- 300.75%1.07M
Special items for working capital changes ---- -599.06%-38.94M ---- 160.75%7.8M ---- -25.69%-12.84M ---- -284.71%-10.22M ---- -106.52%-2.66M
Cash  from business operations ---- 34.40%1.31B ---- 18.04%970.97M ---- 12.32%822.58M ---- 40.35%732.35M ---- 6.24%521.81M
Other taxs ---- -13.60%-163.4M ---- -5.77%-143.84M ---- -38.38%-135.99M ---- 40.03%-98.27M ---- -0.73%-163.88M
Interest received - operating ---- 46.78%53.51M ---- 52.90%36.46M ---- 148.04%23.84M ---- 18.33%9.61M ---- 42.78%8.12M
Special items of business -6.05%507.76M ---- 459.47%540.44M ---- -24.18%96.6M ---- -43.40%127.41M ---- 3,067.93%225.11M ----
Net cash from operations -6.05%507.76M 38.39%1.2B 459.47%540.44M 21.56%863.59M -24.18%96.6M 10.37%710.43M -43.40%127.41M 75.85%643.69M 3,067.93%225.11M 9.55%366.05M
Cash flow from investment activities
Dividend received - investment -7.28%3.59M 1,990.00%92.75M 19.14%3.87M 58.78%4.44M 16.24%3.25M 6.76%2.8M 6.76%2.8M 398.67%2.62M 398.67%2.62M -77.36%525K
Loan receivable (increase) decrease 45.94%3.49M -40.84%7.39M -35.23%2.39M 11.63%12.49M 54.46%3.69M -41.87%11.19M -47.57%2.39M 113.32%19.25M 214.00%4.55M -42.31%9.02M
Decrease in deposits (increase) -386.13%-9.49M -838.55%-25.41M 369.59%3.32M -73.25%3.44M -107.06%-1.23M 173.85%12.86M 335.11%17.42M ---17.42M 120.39%4M ----
Sale of fixed assets -33.99%5.23M 797.10%54.98M 104.70%7.93M 192.41%6.13M 86.60%3.87M -71.67%2.1M 177.78%2.08M 99.43%7.4M 105.79%747K 29.86%3.71M
Purchase of fixed assets -28.24%-248.39M -4.38%-486.68M -78.22%-193.69M -134.98%-466.28M -46.22%-108.68M 5.30%-198.43M -328.43%-74.33M -476.23%-209.55M -85.00%-17.35M 36.87%-36.37M
Purchase of intangible assets ---- ---- ---- ---- ---- -260.30%-28.82M ---- ---8M ---- ----
Sale of subsidiaries ---- -75,360,740.00%-3.77B ---- --5K --50K ---- ---- ---- ---- ----
Acquisition of subsidiaries ---- ---- ---- 126.70%173.92M 120.25%173.92M -656.53%-651.28M -832.63%-858.76M 39,108.67%117.03M --117.22M 88.70%-300K
Recovery of cash from investments -97.90%55.6M -25.58%3.57B 28.19%2.65B 12.05%4.79B 34.19%2.07B -38.23%4.28B -59.44%1.54B 18.48%6.92B 39.22%3.8B 16.46%5.84B
Cash on investment 97.82%-55M 38.76%-2.68B -18.19%-2.53B 18.35%-4.38B 25.15%-2.14B 20.78%-5.37B 39.74%-2.86B -19.13%-6.77B -74.20%-4.74B -17.25%-5.69B
Other items in the investment business -103.64%-16.31M 197.15%620.19M --448.04M -18,847.90%-638.37M ---- --3.41M 150.49%4.09M ---- -134.25%-8.09M 7,973.00%23.62M
Net cash from investment operations -165.53%-261.29M -430.77%-2.62B 5,417.64%398.71M 74.48%-494.02M 100.33%7.23M -3,307.23%-1.94B -166.31%-2.22B -61.61%60.37M -10,833.53%-832.6M -55.76%157.24M
Net cash before financing -73.75%246.48M -486.12%-1.43B 804.55%939.14M 130.15%369.57M 104.97%103.82M -274.08%-1.23B -244.03%-2.09B 34.54%704.05M -4,187.24%-607.49M -24.11%523.29M
Cash flow from financing activities
New borrowing -41.22%1.14B -35.52%5.55B -55.85%1.94B 41.85%8.61B 47.96%4.39B 1,233.95%6.07B 2,139.09%2.97B 386.18%455.24M 1,421.75%132.59M -69.16%93.64M
Refund 32.41%-1.28B 33.03%-5.77B 56.98%-1.9B -69.39%-8.62B -122.59%-4.41B -1,513.32%-5.09B ---1.98B -1,738.65%-315.44M ---- -40,747.62%-17.16M
Interest paid - financing 43.32%-30.88M -106.16%-116.27M -302.93%-54.49M -185.20%-56.4M -65.06%-13.52M -39.06%-19.77M 11.78%-8.19M 15.52%-14.22M -86.82%-9.29M -147.54%-16.83M
Dividends paid - financing ---- 57.33%-55.53M -2,085.82%-11.87M -30.20%-130.14M 99.40%-543K 20.49%-99.96M 21.34%-91.08M 11.72%-125.73M -958.89%-115.78M -9.83%-142.42M
Absorb investment income ---- ---- ---- ---- ---- -65.46%544K ---- 1.29%1.58M -24.03%980K -27.30%1.56M
Other items of the financing business ---- ---- ---- ---474K ---- ---- -345.42%-724K -100.30%-127K -99.27%295K 120.09%42.99M
Net cash from financing operations -426.70%-192.27M -95.40%-437.08M 17.57%-36.5M -126.44%-223.69M -105.03%-44.29M 11,559.71%845.96M 11,387.69%879.84M 81.98%-7.38M -55.44%7.66M 8.39%-40.97M
Effect of rate -73.78%183K -94.84%141K -60.00%698K 16.84%2.73M 139.91%1.75M 253.85%2.34M -461.02%-4.37M -441.28%-1.52M 256.87%1.21M -112.37%-281K
Net Cash -93.99%54.21M -1,377.84%-1.86B 1,416.10%902.64M 138.42%145.88M 104.92%59.54M -154.50%-379.66M -101.74%-1.21B 44.44%696.67M -1,971.48%-599.83M -25.20%482.33M
Begining period cash -60.13%1.24B 5.04%3.1B 5.04%3.1B 9.26%2.95B 9.26%2.95B 34.65%2.7B 34.65%2.7B 31.63%2.01B 31.63%2.01B 73.78%1.52B
Cash at the end -67.76%1.29B -60.13%1.24B 32.88%4B 33.39%3.1B 102.61%3.01B -13.97%2.32B 5.63%1.49B 34.65%2.7B -9.51%1.41B 31.63%2.01B
Cash balance analysis
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards IAS IAS IAS IAS IAS IAS IAS IAS IAS IAS
Audit Opinions -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion
Auditor -- KPMG -- Ernst & Young -- Ernst & Young -- Ernst & Young -- Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data